O. Harris Ford

2.3k total citations · 1 hit paper
16 papers, 1.8k citations indexed

About

O. Harris Ford is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, O. Harris Ford has authored 16 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in O. Harris Ford's work include Prostate Cancer Treatment and Research (12 papers), Hormonal and reproductive studies (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). O. Harris Ford is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Hormonal and reproductive studies (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). O. Harris Ford collaborates with scholars based in United States, Russia and Japan. O. Harris Ford's co-authors include James L. Mohler, Christopher W. Gregory, Frank S. French, Desok Kim, Bin He, Chris Gregory, Emily Wilson, Elizabeth Wilson, Peter Petrusz and Mark Titus and has published in prestigious journals such as Oncogene, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

O. Harris Ford

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Androgen Axis in Recurrent Prostate Cancer

2004 537 citations James L. Mohler, Christopher W. Gregory et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by O. Harris Ford

Since Specialization

Citations

This map shows the geographic impact of O. Harris Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Harris Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Harris Ford more than expected).

Fields of papers citing papers by O. Harris Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Harris Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Harris Ford. The network helps show where O. Harris Ford may publish in the future.

Co-authorship network of co-authors of O. Harris Ford

This figure shows the co-authorship network connecting the top 25 collaborators of O. Harris Ford. A scholar is included among the top collaborators of O. Harris Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Harris Ford. O. Harris Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer 2013 ·Molecular and Cellular Endocrinology ·Jiann-an Tan, Suxia Bai, Gail Grossman, Mark Titus, O. Harris Ford, Elena Pop, Gary J. Smith, James L. Mohler, Elizabeth Wilson, Frank S. French	8
2	14-3-3η Amplifies Androgen Receptor Actions in Prostate Cancer 2009 ·Clinical Cancer Research ·Mark Titus, Jiann-an Tan, Christopher W. Gregory, O. Harris Ford, Romesh R. Subramanian, Haian Fu, Elizabeth M. Wilson, James L. Mohler, Frank S. French	13
3	Comparison of ACINUS, caspase‐3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis 2009 ·The Prostate ·(unknown), Diana Mehedint, O. Harris Ford, (unknown), Elena Pop, Susan J. Maygarden, Anastasia Ivanova, Rameela Chandrasekhar, Gregory E. Wilding, James L. Mohler	9
4	Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer 2008 ·Translational Oncology ·(unknown), Yun Li, O. Harris Ford, (unknown), Diana Mehedint, Mark Titus, James L. Mohler	19
5	Feasibility of constructing tissue microarrays from diagnostic prostate biopsies 2007 ·The Prostate ·(unknown), Diana Mehedint, O. Harris Ford, Susan J. Maygarden, (unknown), James L. Mohler	11
6	Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability 2006 ·The Prostate ·Samarpan Majumder, Yuanbo Liu, O. Harris Ford, James L. Mohler, Young E. Whang	114
7	Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer 2005 ·Clinical Cancer Research ·Mark Titus, Christopher W. Gregory, O. Harris Ford, Michael J. Schell, Susan J. Maygarden, James L. Mohler	145
8	The Androgen Axis in Recurrent Prostate Cancer breakdown → 2004 ·Clinical Cancer Research ·James L. Mohler, Christopher W. Gregory, O. Harris Ford, Desok Kim, (unknown), Peter Petrusz, Elizabeth Wilson, Frank S. French	537
9	Sampling strategy for prostate tissue microarrays for Ki-67 and androgen receptor biomarkers. 2004 ·PubMed ·(unknown), Bahjat F. Qaqish, Jacqueline L. Johnson, O. Harris Ford, Julie F. Foley, Susan J. Maygarden, James L. Mohler	14
10	Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cells 2003 ·Oncogene ·(unknown), (unknown), (unknown), Daqing Wu, (unknown), Christopher W. Gregory, Douglas A. Weidner, O. Harris Ford, (unknown), James L. Mohler, David M. Terrian	91
11	Racial Differences in Androgen Receptor Protein Expression in Men With Clinically Localized Prostate Cancer 2003 ·The Journal of Urology ·Kris E. Gaston, Desok Kim, (unknown), O. Harris Ford, James L. Mohler	113
12	Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer 2003 ·The Journal of Urology ·O. Harris Ford, Christopher W. Gregory, Desok Kim, Andrew B. Smitherman, James L. Mohler	102
13	A novel method for the analysis of the androgen receptor 2002 ·Current Urology Reports ·Kris E. Gaston, O. Harris Ford, (unknown), Christopher W. Gregory, (unknown), Gary J. Smith, James L. Mohler	5
14	Identification of differentially expressed genes associated with androgen‐independent growth of prostate cancer 2002 ·The Prostate ·James L. Mohler, (unknown), O. Harris Ford, (unknown), Choitsu Sakamoto, Christopher W. Gregory	54
15	Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer. 2002 ·PubMed ·Daqing Wu, (unknown), Christopher W. Gregory, (unknown), (unknown), O. Harris Ford, (unknown), James L. Mohler, David M. Terrian	101
16	A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. 2001 ·PubMed ·Chris Gregory, Bin He, (unknown), O. Harris Ford, James L. Mohler, Frank S. French, Emily Wilson	491

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact